Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H32N2O5 |
Molecular Weight | 368.4678 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@H](N(C(=O)[C@H](C)N[C@@H](CCC)C(=O)OCC)[C@@]1([H])CCCC2)C(O)=O
InChI
InChIKey=IPVQLZZIHOAWMC-QRJUGERDSA-N
InChI=1S/C19H32N2O5/c1-4-8-14(19(25)26-5-2)20-12(3)17(22)21-15-10-7-6-9-13(15)11-16(21)18(23)24/h12-16,20H,4-11H2,1-3H3,(H,23,24)/t12-,13+,14-,15-,16-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697
(3AR)-3A-epi-Perindopril is an epimer (S, RS, SS) of the drug perindopril which is commonly used to treat high blood pressure, hypertension, heart failure, or stable coronary artery disease. This epimer possesses equal activity with the parent compound, perindopril.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL1808 Sources: https://www.ncbi.nlm.nih.gov/pubmed/1457697 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
58153637
Created by
admin on Sat Dec 16 08:14:45 GMT 2023 , Edited by admin on Sat Dec 16 08:14:45 GMT 2023
|
PRIMARY | |||
|
KQK78CSH93
Created by
admin on Sat Dec 16 08:14:45 GMT 2023 , Edited by admin on Sat Dec 16 08:14:45 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD